The Track XI system (Microbiological Associates, Bethesda, Md.) was compared with the Bio-EnzaBead assay (Organon Teknika, Durham, N.C.) for the detection of antibody to mouse hepatitis virus (MHV). Strain A/J mice were inoculated intranasally with MHV type 3. Sera were collected at 1, 2, 4, and 9 weeks postinoculation and tested. Individual serum samples were retested twice by each tubes, allowed to clot, and centrifuged at 13,600 x g for 2 min. The sera were stored at -70°C. Two control mice were euthanatized before the experiment began to confirm negative MHV titers. Five control mice were euthanatized 9 weeks after the experiment began. Euthanasia and blood collection procedures for control mice were identical to those used for experimental mice. The nasal passages, sinuses, lungs, livers, and gastrointestinal tracts were collected from all mice. The tissues were fixed with 10% neutral buffered Formalin, embedded in paraffin, and stained with hematoxylin and eosin.
Mouse hepatitis is a common infectious disease of mice which is caused by a coronavirus. Several factors affect the clinical and pathologic manifestations of the disease, including the strain of the virus and the strain of mouse infected. The disease alters the immune response and can adversely affect experimental results (7) . Since signs and lesions may be minimal or totally absent in resistant strains of mice (7) (8) (9) , serologic testing is a primary method of diagnosis.
Two commercially produced serologic testing systems detect antibody to mouse hepatitis virus (MHV) Mild focal hepatitis associated with viral antigen in macrophages and occasional hepatocytes was noted in mice at 7 days postinoculation. Table 1 summarizes the results of the serologic assays.
Positive antibody titers were found in four of five mice by the FIA in the first test run at 1 week postinoculation, whereas the ELISA detected only one positive serum. Retesting of sera at 1 week postinoculation showed relatively high reproducibility for both the FIA and the ELISA. At 2, 4, and 9 weeks postinoculation, the FIA gave more positive results with a higher degree of reproducibility than the ELISA. A total of 19 sera were tested three times each. Although two of these sera showed poor reproducibility with the FIA, the lack of reproducibility or reliability with the ELISA (10 of 19 results) was significantly greater (P < 0.01). The FIA also detected a greater number of positive samples than the ELISA (P < 0.01). Samples from control mice remained negative for all three test runs with the FIA. With the ELISA, one control sample tested positive in two of the three test runs.
The presence of MHV infection after intranasal inoculation was confirmed by immunoperoxidase demonstration of antigen within cells and by typical hepatic lesions. These results were similar to those obtained by other investigators (1, 2) . The serologic results suggest that the Track XI FIA was more sensitive and reproducible than the Bio-EnzaBead ELISA for A/J mice infected with MHV3. In a similar comparison, the Track XI assay for detection of antibody to Brucella abortus in cattle was found to be more sensitive than either the ELISA or the FIAX FIA (4) .
The serious discrepancies between the ELISA and the FIA in our study were not apparent until positive sera were compared. There was no consistent change which would specifically suggest poor technique, reagent failure, or improper incubation times. Positive and negative control values for the ELISA were within normal expected ranges. Although technical error cannot be ruled out, it is not the only possible explanation for our data.
The results of a previous study comparing an immunofluorescence test and the Bio-EnzaBead ELISA (10) indicated that reactions of Bio-EnzaBead with MHV3 and MHV-JHM strains were weaker than reactions with other MHV strains tested. In an earlier study (8) , no neutralizing antibody was found in serum of A/J mice 15 days after intraperitoneal inoculation with MHV3. In fact, a general conclusion has been drawn from a review of several studies of MHV in mice (7) that the classic humoral immune response to MHV appears to be weak. The poor results obtained with the ELISA reported here might be explained by a weak humoral response, except that positive titers were consistently obtained with the FIA. Perhaps antigenic sites within the colloidal gel are more available to serum antibody than are sites on the ferrous beads or the magnitude of the fluorescence reaction is so much greater compared with the color change in the enzyme reaction that smaller amounts of antibody can be detected. For whatever reason, our results suggest that the Track XI FIA is sensitive and reliable in detecting antibody to MHV3 in A/J mice, despite the poor humoral response to this strain of virus.
